Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1990 Mar;43(3):177–183. doi: 10.1136/jcp.43.3.177

Guidelines on oral anticoagulation: second edition. British Society for Haematology. British Committee for Standards in Haematology. Haemostasis and Thrombosis Task Force.

PMCID: PMC502325  PMID: 2185281

Full text

PDF
177

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Duxbury B. M. Therapeutic control of anticoagulant treatment. Br Med J (Clin Res Ed) 1982 Mar 6;284(6317):702–704. doi: 10.1136/bmj.284.6317.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Francis C. W., Marder V. J., Evarts C. M., Yaukoolbodi S. Two-step warfarin therapy. Prevention of postoperative venous thrombosis without excessive bleeding. JAMA. 1983 Jan 21;249(3):374–378. doi: 10.1001/jama.249.3.374. [DOI] [PubMed] [Google Scholar]
  3. Hirsh J., Poller L., Deykin D., Levine M., Dalen J. E. Optimal therapeutic range for oral anticoagulants. Chest. 1989 Feb;95(2 Suppl):5S–11S. [PubMed] [Google Scholar]
  4. Hull R., Hirsh J., Jay R., Carter C., England C., Gent M., Turpie A. G., McLoughlin D., Dodd P., Thomas M. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med. 1982 Dec 30;307(27):1676–1681. doi: 10.1056/NEJM198212303072704. [DOI] [PubMed] [Google Scholar]
  5. Hyers T. M., Hull R. D., Weg J. G. Antithrombotic therapy for venous thromboembolic disease. Chest. 1989 Feb;95(2 Suppl):37S–51S. doi: 10.1378/chest.95.2_supplement.37s. [DOI] [PubMed] [Google Scholar]
  6. Kirkwood T. B. Calibration of reference thromboplastins and standardisation of the prothrombin time ratio. Thromb Haemost. 1983 Jun 28;49(3):238–244. [PubMed] [Google Scholar]
  7. Lewis S. M. Thromboplastin and oral anticoagulant control. Br J Haematol. 1987 May;66(1):1–4. [PubMed] [Google Scholar]
  8. Petersen P., Boysen G., Godtfredsen J., Andersen E. D., Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet. 1989 Jan 28;1(8631):175–179. doi: 10.1016/s0140-6736(89)91200-2. [DOI] [PubMed] [Google Scholar]
  9. Poller L., Taberner D. A., Thomson J. M., Darby K. V. Survey of prothrombin time in National External Quality Assessment Scheme exercises (1980-87). J Clin Pathol. 1988 Apr;41(4):361–364. doi: 10.1136/jcp.41.4.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Resnekov L., Chediak J., Hirsh J., Lewis H. D., Jr Antithrombotic agents in coronary artery disease. Chest. 1989 Feb;95(2 Suppl):52S–72S. doi: 10.1378/chest.95.2_supplement.52s. [DOI] [PubMed] [Google Scholar]
  11. SEVITT S. Venous thrombosis and pulmonary embolism. Their prevention by oral anticoagulants. Am J Med. 1962 Nov;33:703–716. doi: 10.1016/0002-9343(62)90248-6. [DOI] [PubMed] [Google Scholar]
  12. Shinton N. K. Standardisation of oral anticoagulant treatment. Br Med J (Clin Res Ed) 1983 Oct 8;287(6398):1000–1001. doi: 10.1136/bmj.287.6398.1000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Stein P. D., Kantrowitz A. Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein bypass grafts. Chest. 1989 Feb;95(2 Suppl):107S–117S. doi: 10.1378/chest.95.2_supplement.107s. [DOI] [PubMed] [Google Scholar]
  14. Taberner D. A., Poller L., Burslem R. W., Jones J. B. Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis. Br Med J. 1978 Feb 4;1(6108):272–274. doi: 10.1136/bmj.1.6108.272. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES